Aspects of the present application relate to process for the preparation of crystalline propane-1,2,3-triol solvate of dapagliflozin, process for the preparation of L-proline complex of dapagliflozin and pharmaceutical formulations of crystalline propane-1,2,3-triol solvate of dapagliflozin.